Gainers

Allena Pharmaceuticals, Inc. ALNA stock increased by 35.29% to $2.99 during Tuesday's pre-market session. The most recent rating by HC Wainwright & Co., on Jun 1, is at Buy, with a price target of $10.

Trevena, Inc. TRVN stock increased by 15.79% to $1.54.

Tetraphase Pharmaceutical, Inc. TTPH shares rose 9.91% to $2.55. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Cleveland BioLabs, Inc. CBLI stock moved upwards by 9.39% to $1.98.

AcelRx Pharmaceuticals, Inc. ACRX stock moved upwards by 8.66% to $1.38. The most recent rating by H.C. Wainwright, on Mar 17, is at Buy, with a price target of $7.

China Jo-Jo Drugstores, Inc. CJJD stock increased by 7.35% to $1.46.

Nabriva Therapeutics, Inc. NBRV stock increased by 6.91% to $0.83. According to the most recent rating by H.C. Wainwright, on Apr 9, the current rating is at Neutral.

ZIOPHARM Oncology, Inc. ZIOP shares rose 6.64% to $3.21. The most recent rating by HC Wainwright & Co., on May 11, is at Buy, with a price target of $6.

Aerpio Pharmaceuticals, Inc. ARPO shares increased by 6.36% to $1.17.

Millendo Therapeutics, Inc. MLND shares rose 5.44% to $2.52. The most recent rating by Citigroup, on May 29, is at Buy, with a price target of $6.

 

Losers

Iterum Therapeutics, Inc. ITRM stock fell 7.06% to $1.58 during Tuesday's pre-market session. The most recent rating by SVB Leerink, on Jun 2, is at Market Perform, with a price target of $1.

Sundial Growers, Inc. SNDL shares decreased by 6.60% to $0.80.

Capital Senior Living, Inc. CSU stock fell 6.17% to $0.61.

Aileron Therapeutics, Inc. ALRN stock declined 6.12% to $1.38. The most recent rating by H.C. Wainwright, on Mar 31, is at Buy, with a price target of $3.

Immunic, Inc. IMUX stock decreased by 5.04% to $12.05. The most recent rating by H.C. Wainwright, on May 11, is at Buy, with a price target of $45.

Citius Pharmaceuticals, Inc. CTXR shares fell 4.60% to $0.85.

Capricor Therapeutics, Inc. CAPR shares fell 4.57% to $4.59.

Ocugen, Inc. OCGN shares declined 4.35% to $0.22. According to the most recent rating by HC Wainwright & Co., on Jun 1, the current rating is at Neutral.

CTI BioPharma, Inc. CTIC shares fell 3.36% to $1.15.

InVivo Therapeutics Hldg, Inc. NVIV shares fell 3.23% to $1.50.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!